Khouri-Farah N, Winchester E, Schilder B, Robinson K, Curtis S, Skene N
bioRxiv. 2025; .
PMID: 39868299
PMC: 11761091.
DOI: 10.1101/2025.01.18.633396.
Kim J, Koh D, Lee M, Park Y, Hong S, Shin J
Cell Death Differ. 2023; 30(12):2491-2507.
PMID: 37926711
PMC: 10733321.
DOI: 10.1038/s41418-023-01235-9.
Nakata T, Li C, Mayassi T, Lin H, Ghosh K, Segerstolpe A
Sci Transl Med. 2023; 15(719):eadg5252.
PMID: 37878672
PMC: 10798370.
DOI: 10.1126/scitranslmed.adg5252.
Podschwadt P, Malyshkina A, Windmann S, Werner T, Hansen W, Bayer W
Retrovirology. 2022; 19(1):29.
PMID: 36527061
PMC: 9758943.
DOI: 10.1186/s12977-022-00613-4.
Cazes A, Childers B, Esparza E, Lowy A
Cancers (Basel). 2022; 14(8).
PMID: 35454943
PMC: 9027306.
DOI: 10.3390/cancers14082037.
Genetic Investigation of Inverse Psoriasis.
Goblos A, Varga E, Farkas K, Arvai K, Kemeny L
Life (Basel). 2021; 11(7).
PMID: 34357026
PMC: 8306123.
DOI: 10.3390/life11070654.
RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets.
Chen S, Wang G, Shi D, Yao S, Chen K, Yao H
World J Gastroenterol. 2021; 27(20):2507-2520.
PMID: 34092972
PMC: 8160627.
DOI: 10.3748/wjg.v27.i20.2507.
Tumor cell intrinsic RON signaling suppresses innate immune responses in breast cancer through inhibition of IRAK4 signaling.
Bourn J, Ruiz-Torres S, Hunt B, Benight N, Waltz S
Cancer Lett. 2021; 503:75-90.
PMID: 33508385
PMC: 7981256.
DOI: 10.1016/j.canlet.2021.01.019.
Recepteur d'origine nantais contributes to the development of endometriosis via promoting epithelial-mesenchymal transition of a endometrial epithelial cells.
Yu Q, Wang J, Li T, Guo X, Ding S, Che X
J Cell Mol Med. 2021; 25(3):1601-1612.
PMID: 33410267
PMC: 7875913.
DOI: 10.1111/jcmm.16261.
Macrophage-Stimulating Protein Enhances Osteoblastic Differentiation via the Recepteur d'Origine Nantais Receptor and Extracellular Signal-Regulated Kinase Signaling Pathway.
Jeong B, Oh S, Lee M, Koh J
J Bone Metab. 2020; 27(4):267-279.
PMID: 33317230
PMC: 7746481.
DOI: 10.11005/jbm.2020.27.4.267.
MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
Huang L, Fang X, Shi D, Yao S, Wu W, Fang Q
Front Immunol. 2020; 11:569082.
PMID: 33117355
PMC: 7577085.
DOI: 10.3389/fimmu.2020.569082.
Targeting RON receptor tyrosine kinase for treatment of advanced solid cancers: antibody-drug conjugates as lead drug candidates for clinical trials.
Yao H, Suthe S, Tong X, Wang M
Ther Adv Med Oncol. 2020; 12:1758835920920069.
PMID: 32426050
PMC: 7222236.
DOI: 10.1177/1758835920920069.
OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase.
Hao C, Cui Y, Chang S, Huang J, Birkin E, Hu M
Sci Rep. 2019; 9(1):18101.
PMID: 31792339
PMC: 6889187.
DOI: 10.1038/s41598-019-54843-2.
MSP-RON Signaling Is Activated in the Transition From Pancreatic Intraepithelial Neoplasia (PanIN) to Pancreatic Ductal Adenocarcinoma (PDAC).
Li C, Morvaridi S, Lam G, Chheda C, Kamata Y, Katsumata M
Front Physiol. 2019; 10:147.
PMID: 30863319
PMC: 6399467.
DOI: 10.3389/fphys.2019.00147.
Therapeutic Considerations for Ron Receptor Expression in Prostate Cancer.
Brown N, Sullivan C, Waltz S
EMS Cancer Sci J. 2019; 1(1).
PMID: 30775725
PMC: 6377156.
Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
Lu T, Wang Z, Prativa S, Xu Y, Wang T, Zhang Y
J Neurochem. 2018; 148(1):114-126.
PMID: 30380151
PMC: 6333517.
DOI: 10.1111/jnc.14622.
A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing.
Basu A, Munir S, Mulaw M, Singh K, Crisan D, Sindrilaru A
Sci Rep. 2018; 8(1):6205.
PMID: 29670130
PMC: 5906602.
DOI: 10.1038/s41598-018-24425-9.
Molecular Mechanisms Modulating the Phenotype of Macrophages and Microglia.
Amici S, Dong J, Guerau-de-Arellano M
Front Immunol. 2017; 8:1520.
PMID: 29176977
PMC: 5686097.
DOI: 10.3389/fimmu.2017.01520.
Immunomodulatory Potential of the Polysaccharide-Rich Extract from Edible Cyanobacterium .
Liao H, Wu T, Tai J, Chi M, Lin L
Med Sci (Basel). 2017; 3(4):112-123.
PMID: 29083396
PMC: 5635763.
DOI: 10.3390/medsci3040112.
Role of Recepteur D'origine Nantais on Gastric Cancer Development and Progression.
Yang S, Nguyen T, Ung T, Do Jung Y
Chonnam Med J. 2017; 53(3):178-186.
PMID: 29026705
PMC: 5636756.
DOI: 10.4068/cmj.2017.53.3.178.